Pharmacoeconomic research of using aflibercept in patients with the wet age-related macular degeneration
Purpose. To evaluate the economic and clinical results of the aflibercept and ranibizumab angiogenesis inhibitors in the treat-and-extend regimen in patients with the “wet” form of age-related macular degeneration (wAMD). Materials and methods. We analyzed cost minimization, impact on the budget and...
Uloženo v:
| Hlavní autoři: | , , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Russo |
| Vydáno: |
Real Time Ltd
2020-03-01
|
| Edice: | Российский офтальмологический журнал |
| Témata: | |
| On-line přístup: | https://roj.igb.ru/jour/article/view/379 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|